摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(3-isobutoxyphenyl)propanoic acid | 1057602-15-9

中文名称
——
中文别名
——
英文名称
3-(3-isobutoxyphenyl)propanoic acid
英文别名
3-(2-Methylpropoxy)benzenepropanoic acid;3-[3-(2-methylpropoxy)phenyl]propanoic acid
3-(3-isobutoxyphenyl)propanoic acid化学式
CAS
1057602-15-9
化学式
C13H18O3
mdl
——
分子量
222.284
InChiKey
NPMWJRMKDHLMEN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    16
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS
    申请人:Gschneidner David
    公开号:US20110046050A1
    公开(公告)日:2011-02-24
    The present invention provides phenylalkylcarboxylic acid compounds and compositions containing such compounds which facilitate the delivery of biologically active agents.
    本发明提供苯基烷基羧酸化合物及含有此类化合物的组合物,有助于传递生物活性物质。
  • Phenylalkylcarboxylic acid delivery agents
    申请人:Emisphere Technologies, Inc.
    公开号:US10456472B2
    公开(公告)日:2019-10-29
    The present invention provides phenylalkylcarboxylic acid compounds and compositions containing such compounds which facilitate the delivery of biologically active agents.
    本发明提供了苯基烷基羧酸化合物和含有此类化合物的组合物,它们有助于生物活性剂的递送。
  • COMPOSITIONS OF PENTOSAN POLYSULFATE SALTS FOR ORAL ADMINISTRATION AND METHODS OF USE
    申请人:Urigen Pharmaceuticals, Inc.
    公开号:EP3110427A1
    公开(公告)日:2017-01-04
  • COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES AND CONDITIONS EMPLOYING ORAL ADMINISTRATION OF SODIUM PENTOSAN POLYSULFATE AND OTHER PENTOSAN POLYSULFATE SALTS
    申请人:PARSONS C. Lowell
    公开号:US20170189443A1
    公开(公告)日:2017-07-06
    The present invention is directed to a pharmaceutical composition comprising: (1) a therapeutically effective quantity of sodium pentosan polysulfate; (2) a quantity of a penetration enhancer sufficient to improve the bioavailability of the sodium pentosan polysulfate; and (3) optionally, a pharmaceutically acceptable carrier and to methods for the oral administration of sodium pentosan polysulfate with improved bioavailability for the treatment of interstitial cystitis and other urinary tract diseases and conditions. Such compositions and methods allow the administration of sodium pentosan polysulfate at lower dosages to reduce the frequency and severity of side effects.
  • [EN] PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS<br/>[FR] AGENTS DE DISTRIBUTION D'ACIDE PHÉNYLALKYLCARBOXYLIQUE
    申请人:EMISPHERE TECH INC
    公开号:WO2008112368A2
    公开(公告)日:2008-09-18
    [EN] The present invention provides phenylalkylcarboxylic acid compounds and compositions containing such compounds which facilitate the delivery of biologically active agents.
    [FR] L'invention concerne des composés acide phénylalkylcarboxylique et des compositions contenant de tels composés qui facilitent la distribution d'agents biologiquement actifs.
查看更多